ACAD | ACADIA Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: San Diego, California, United States Trade prices Volume: Market Cap: 2.32B Prev closed: Open: 22.31 High: 22.91 Low: 21.38 52 week low: 15.68 52 week high: 54.58 Dividends: No Dividends Next ER: November 7, 2022
About the Company Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Earnings History Date EPS / Forecast Revenue / Forecast February 27, 2023 November 2, 2022 -0.17 / -0.19130.7M / 138.64MAugust 8, 2022 -0.21 / -0.2478134.56M / 130.41MBeat! May 4, 2022 -0.7 / -0.6179115.47M / 121.91MFebruary 28, 2022 -0.27 / -0.2376130.76M / 135.39Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 8, 2022 16.62 16.14 16.96
16.14
2.06M 1.09% Aug 5, 2022 16.44 15.21 16.97
14.95
4.05M 5.25% Aug 4, 2022 15.62 15.26 15.72
14.89
1.80M 4.34% Aug 3, 2022 14.97 15.38 15.81
14.93
2.18M -0.27% Aug 2, 2022 15.01 14.08 15.06
13.80
1.43M 6.38% Aug 1, 2022 14.11 14.56 14.96
14.08
1.97M -3.95% Jul 29, 2022 14.69 14.52 14.74
14.18
1.35M 0.75% Jul 28, 2022 14.58 14.79 14.85
14.31
1.08M -1.29% Jul 27, 2022 14.77 14.21 14.80
14.05
1.34M 4.31% Jul 26, 2022 14.16 14.27 14.49
14.08
1.10M -0.49% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1993 Employees:490 News
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results finance.yahoo.com Nov 7, 2022 4:05 pm
Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results finance.yahoo.com Nov 7, 2022 4:05 pm
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates finance.yahoo.com Nov 7, 2022 11:06 am Acadia Pharmaceuticals downgraded to sell at Goldman Sachs following Q3 earnings seekingalpha.com Nov 4, 2022 9:45 pm Acadia Pharmaceuticals sees Q3 mixed bag as it beats on bottom line but misses on top seekingalpha.com Nov 3, 2022 5:08 am ACADIA Pharma GAAP EPS of -$0.17 beats by $0.02, revenue of $130.71M misses by $8.33M seekingalpha.com Nov 3, 2022 4:20 am
Acadia Pharmaceuticals Recognizes Rett Syndrome Awareness Month and Launches New Awareness Campaign, Rett Revealed finance.yahoo.com Nov 7, 2022 7:30 am
Acadia's (ACAD) Q3 Loss Narrower Than Expected, Revenues Miss finance.yahoo.com Nov 3, 2022 12:23 pm ACADIA Pharma Q3 2022 Earnings Preview seekingalpha.com Nov 2, 2022 5:35 am
Acadia Pharmaceuticals Announces Planned Retirement of President Srdjan (Serge) Stankovic finance.yahoo.com Oct 27, 2022 4:05 pm
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy? finance.yahoo.com Oct 26, 2022 10:02 am
Acadia Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 finance.yahoo.com Oct 20, 2022 4:05 pm
Acadia Pharmaceuticals Appoints Adora Ndu, Pharm.D., J.D. to its Board of Directors finance.yahoo.com Oct 13, 2022 7:30 am
Acadia (ACAD) Rises More Than 14% in 3 Months: Here's Why finance.yahoo.com Oct 6, 2022 1:36 pm FDA accepts Acadia's new drug application for Rett syndrome treatment trofinetide seekingalpha.com Sep 13, 2022 1:50 am
Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA finance.yahoo.com Sep 12, 2022 7:30 am
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences finance.yahoo.com Sep 1, 2022 9:03 am
Acadia (ACAD) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com Aug 26, 2022 12:00 pm ACADIA Pharma GAAP EPS of -$0.21 beats by $0.05, revenue of $134.56M beats by $4.5M seekingalpha.com Aug 9, 2022 4:11 am
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Alzheimers Disease Psychosis finance.yahoo.com Aug 8, 2022 11:05 pm This company doesn't provide a dividend.
Talk about ACADIA Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 33 HOLD 67 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.